Velocity’s research site in Durham opened its doors in 2023 and offers Phase 1-4 multi-therapeutic clinical research experience, including extensive experience with vaccine indications. Other experience includes Women’s Health, Dermatology, Gastroenterology and Internal Medicine indications. Patient demographics of the site are diverse and range from pediatric to geriatric participants.
Located near the center of Durham in the same building as Velocity’s HQ, the site is easily accessible for participants. In this large, dedicated research space, our Durham staff can efficiently and effectively conduct multiple concurrent studies. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Velocity Durham team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
